inploi secures £3m seed to automate high-volume recruitment and cut manual work
This article covers inploi, a healthtech startup, which has raised £3m in a seed funding round to expand its talent platform and accelerate product development. The funding is intended to grow commercial and product teams and to scale Talent Agents, a suite of automation tools that reduce manual work in high-volume recruitment and support employers in sectors such as hospitality, retail, healthcare and NHS trusts.
inploi has raised £3 million in a seed funding round to expand its talent platform and accelerate product development. The capital will be used to grow commercial and product teams and to push further development of Talent Agents, a suite of automation tools designed to reduce manual work in high-volume recruitment.
Why it matters
High-volume recruitment remains a persistent operational challenge across sectors such as hospitality, retail and healthcare, where employers must process large numbers of applications quickly while maintaining candidate engagement. Tools that sit alongside applicant tracking systems and automate routine tasks can cut time-to-hire and reduce candidate drop-off, a particular priority for NHS trusts and other public-sector employers facing staffing pressure.
The funding positions inploi to scale those capabilities at a time when organisations are balancing tight hiring targets with the need to improve the candidate experience.
Inside the product
inploi provides software that integrates with applicant tracking systems to streamline candidate journeys. Its Talent Agents are designed to automate sourcing, screening, scheduling and candidate communications, enabling more personalised engagement at scale and freeing talent teams to focus on higher-value interactions.
The company says its platform has supported millions of job applications across more than 70,000 vacancies. It has signed more than 30 enterprise customers and lists clients across hospitality, leisure, healthcare, construction, government and retail, including Compass Group, Wagamama, Gail’s, PureGym and multiple NHS trusts. The firm has also expanded into the United States, pointing to demand from employers dealing with rising application volumes.
Who are the investors?
The round was led by YFM Equity Partners with additional support from existing investors. The £3 million injection is earmarked for building sales and marketing capability, expanding the team and accelerating development of the Talent Agents product.
In the announcement, Roshan Puri, Partner at YFM Equity Partners, said:
inploi is addressing a real and growing challenge for enterprise employers. The team has built a compelling product with clear customer ROI and strong momentum in the UK and US. We're delighted to support inploi on its startup journey.
If you're researching potential backers in this space:
- Explore our list of healthtech venture capital firms in the UK
- Browse our directory of healthtech angel investors in the UK
Founder perspective
In the announcement, Matthew de la Hey, Co-founder & CEO at inploi, said:
Employers are under huge pressure to hire at scale while delivering a better experience for candidates. inploi has proven there’s a better way to do this, and we’re seeing strong demand from organisations that want smarter, more efficient recruitment. YFM’s backing allows us to accelerate our growth, invest further in our product and scale the business internationally.
The bigger picture
The deal reflects continued investor interest in tools that help employers hire at scale while improving candidate experience, a theme especially relevant to health and care employers. For recruitment technology more broadly, the challenge is less about replacing applicant tracking systems and more about adding automation and orchestration that reduce manual work and show clear return on investment.
As UK startups look to export services, inploi’s US expansion underlines a pattern of domestic talent-technology vendors seeking larger addressable markets overseas. For the UK and European ecosystem, deals like this show that investors remain willing to back product-led startups that tie automation to measurable hiring outcomes.
They've invested in inploi
Get to know these healthtech investors
Click here for a full list of 7,589+ startup investors in the UK